SRRK: Scholar Rock Holding Corporation Stock

by  •  • Comments Off on SRRK: Scholar Rock Holding Corporation Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 3,080.78
Enterprise Value ($M) 2,702.86
Book Value ($M) 368.63
Book Value / Share 3.89
Price / Book 8.36
NCAV ($M) 344.88
NCAV / Share 3.64
Price / NCAV 8.93

Profitability (mra)
Return on Invested Capital (ROIC) -0.56
Return on Assets (ROA) -0.92
Return on Equity (ROE) -1.35

Liquidity (mrq)
Quick Ratio 9.61
Current Ratio 9.61

Balance Sheet (mrq) ($M)
Current Assets 451.17
Assets 474.92
Liabilities 106.29
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -252.05
Net Income -246.29
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -200.95
Cash from Investing -76.06
Cash from Financing 353.03

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Redmile Group, LLC 9.90 19.08
02-12 13G/A Invus Global Management, LLC 11.40 -15.66
02-12 13G/A Fmr Llc 15.00 32.22
11-14 13G/A Orbimed Advisors Llc 0.60 -82.99
11-14 13G/A Price T Rowe Associates Inc /md/ 10.80 -3.46
11-12 13G/A Vanguard Group Inc 5.04 0.00
10-07 13D/A Samsara BioCapital, L.P. 8.30 -14.23

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-03 268,320 865,692 30.99
2025-04-02 201,820 1,309,359 15.41
2025-04-01 603,654 1,922,845 31.39
2025-03-31 288,534 1,116,550 25.84

(click for more detail)

Similar Companies
SNDX – Syndax Pharmaceuticals, Inc. SPRO – Spero Therapeutics, Inc.
SRPT – Sarepta Therapeutics, Inc. STOK – Stoke Therapeutics, Inc.
STTK – Shattuck Labs, Inc.


Financial data and stock pages provided by
Fintel.io